Cellev8 Nutrition Inc.

CELVOTCTechnology● Active

$0.08

+$0.00(+0.00%)

Market Cap$10718822

P/E Ratio—

52W High$0.89

52W Low$0.03

Avg Volume15K

Open$0.07

Beta-3.12

Free Cash Flow Financials Revenue

Cellev8 Nutrition Inc. (CELV) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CELV · free cash flow · updated Jun 8, 2026

Core FCF metrics

CELV · FCF · TTM · margin & CAGR

Free cash flow was −$1.8M for FY2025 (fiscal year ending 2025-11-30), down 32.4% year-over-year The FCF margin was -639.1%.

FY2025 Free Cash Flow−$1.8M▼ -32.4% YoY

Trailing 12M (TTM)−$1.3Mtrailing 4 quarters sum

FCF Margin-639.1%−$1.8M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CELV · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$1.8M(0M)−$1.8M▼ 32.4%-639.1%

FY2024−$1.4M(0M)−$1.4M▼ 90.3%-689.5%

FY2023−$720,289(0M)−$720,290▼ 52.3%-307.0%

FY2022−$472,380(0M)−$473,060▲ +19.7%—

FY2021−$582,565(0M)−$588,805▲ +64.7%—

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CELV · P/FCF · FCF yield · FCF per share

Cellev8 Nutrition Inc. (CELV) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-11-30

Cash flow statement summary

CELV · cash flow statement · operating / investing / financing

For FY2025, Cellev8 Nutrition Inc. generated −$1.8M in operating cash flow and spent 0M in capital expenditures, yielding −$1.8M in free cash flow.

Operating Activities

−$1.8M

Cash from core business operations

2025-11-30

Investing Activities

−$0.0M

CapEx, acquisitions & investments

2025-11-30

Financing Activities

+$2.1M

Buybacks, dividends & debt

2025-11-30

FCF FormulaOperating CF (−$1.8M) − |CapEx| (0M) = FCF (−$1.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Technology)

CELV vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Cellev8 Nutrition Inc.YOU

CELV

−$1.8M-32.4%-639.1%

Loss

Taiwan Semiconductor Manufacturing Company Limited

Microsoft Corporation

Technology · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Cellev8 Nutrition Inc. (CELV) reported free cash flow of −$1.8M for FY2025 (fiscal year ending 2025-11-30), down 32.4% year-over-year. The FCF margin was -639.1%.

Cellev8 Nutrition Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 15 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CELV free cash flow · 8 questions

Cellev8 Nutrition Inc. free cash flow was −$1.8M for FY2025, down 32.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$1.3M.

CELV free cash flowCELV FCFCELV FCF 2025CELV free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Cellev8 Nutrition Inc. · Cellev8 Nutrition Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026